These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 36267276)

  • 1. Role of CD40(L)-TRAF signaling in inflammation and resolution-a double-edged sword.
    Strohm L; Ubbens H; Münzel T; Daiber A; Daub S
    Front Pharmacol; 2022; 13():995061. PubMed ID: 36267276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of inflammatory signaling pathways involving the CD40-CD40L-TRAF cascade in diabetes and hypertension-insights from animal and human studies.
    Strohm L; Daiber A; Ubbens H; Krishnankutty R; Oelze M; Kuntic M; Hahad O; Klein V; Hoefer IE; von Kriegsheim A; Kleinert H; Atzler D; Lurz P; Weber C; Wild PS; Münzel T; Knosalla C; Lutgens E; Daub S
    Basic Res Cardiol; 2024 Mar; ():. PubMed ID: 38554187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease-The Pros and Cons for Cardioprotection.
    Daub S; Lutgens E; Münzel T; Daiber A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.
    Seijkens TTP; van Tiel CM; Kusters PJH; Atzler D; Soehnlein O; Zarzycka B; Aarts SABM; Lameijer M; Gijbels MJ; Beckers L; den Toom M; Slütter B; Kuiper J; Duchene J; Aslani M; Megens RTA; van 't Veer C; Kooij G; Schrijver R; Hoeksema MA; Boon L; Fay F; Tang J; Baxter S; Jongejan A; Moerland PD; Vriend G; Bleijlevens B; Fisher EA; Duivenvoorden R; Gerdes N; de Winther MPJ; Nicolaes GA; Mulder WJM; Weber C; Lutgens E
    J Am Coll Cardiol; 2018 Feb; 71(5):527-542. PubMed ID: 29406859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
    Zirlik A; Bavendiek U; Libby P; MacFarlane L; Gerdes N; Jagielska J; Ernst S; Aikawa M; Nakano H; Tsitsikov E; Schönbeck U
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1101-7. PubMed ID: 17332487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders.
    Chand Dakal T; Dhabhai B; Agarwal D; Gupta R; Nagda G; Meena AR; Dhakar R; Menon A; Mathur R; Mona ; Yadav V; Sharma A
    Immunobiology; 2020 Mar; 225(2):151899. PubMed ID: 31899051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.
    Bosmans LA; Bosch L; Kusters PJH; Lutgens E; Seijkens TTP
    J Cardiovasc Transl Res; 2021 Feb; 14(1):13-22. PubMed ID: 32222950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 signaling in vascular cells: a key role in atherosclerosis?
    Mach F; Schönbeck U; Libby P
    Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease.
    Rizvi M; Pathak D; Freedman JE; Chakrabarti S
    Trends Mol Med; 2008 Dec; 14(12):530-8. PubMed ID: 18977174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the CD40-CD40 Ligand Pathway in Cardiovascular Events, Neurological Alterations, and Other Clinical Complications of Chronic Hemodialysis Patients: Protective Role of Adsorptive Membranes.
    Marengo M; Migliori M; Merlotti G; Fabbrini P; Panichi V; Cantaluppi V
    Blood Purif; 2023 Jun; 52(Suppl 1):1-16. PubMed ID: 37331328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease.
    Lacy M; Bürger C; Shami A; Ahmadsei M; Winkels H; Nitz K; van Tiel CM; Seijkens TTP; Kusters PJH; Karshovka E; Prange KHM; Wu Y; Brouns SLN; Unterlugauer S; Kuijpers MJE; Reiche ME; Steffens S; Edsfeldt A; Megens RTA; Heemskerk JWM; Goncalves I; Weber C; Gerdes N; Atzler D; Lutgens E
    Nat Commun; 2021 Jun; 12(1):3754. PubMed ID: 34145241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD40/CD40L system regulates rat cerebral microvasculature after focal ischemia/reperfusion via the mTOR/S6K signaling pathway.
    Jiang RH; Xu XQ; Wu CJ; Lu SS; Zu QQ; Zhao LB; Liu S; Shi HB
    Neurol Res; 2018 Sep; 40(9):717-723. PubMed ID: 29843579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40L and its role in essential hypertension: diagnostic and therapeutic implications.
    Ferroni P; Guadagni F
    Cardiovasc Hematol Disord Drug Targets; 2008 Sep; 8(3):194-202. PubMed ID: 18781932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion.
    Ishikawa M; Vowinkel T; Stokes KY; Arumugam TV; Yilmaz G; Nanda A; Granger DN
    Circulation; 2005 Apr; 111(13):1690-6. PubMed ID: 15795333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells.
    Merz C; Sykora J; Marschall V; Richards DM; Heinonen K; Redondo Müller M; Thiemann M; Schnyder T; Fricke H; Hill O; Gieffers C
    J Immunother; 2018; 41(9):385-398. PubMed ID: 30273198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligand: a novel target in the fight against cardiovascular disease.
    Vishnevetsky D; Kiyanista VA; Gandhi PJ
    Ann Pharmacother; 2004 Sep; 38(9):1500-8. PubMed ID: 15280513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells.
    Chakrabarti S; Rizvi M; Pathak D; Kirber MT; Freedman JE
    Immunol Lett; 2009 Feb; 122(2):170-84. PubMed ID: 19187784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.